Quantcast

Latest Lymphoma Stories

2014-09-17 08:28:52

Pivotal Phase 3 Clinical Trial Targeted to Begin in First Half of 2015 PRINCETON, N.J., Sept. 17, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that agreement has been reached with the US Food and Drug Administration (FDA) on the design of a pivotal, Phase 3 clinical trial evaluating its...

2014-09-17 04:21:18

- Total Deal Valued at up to Approximately $133.5 Million; Approximately $18.1 million Upfront - SEATTLE, Sept. 17, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) and Servier today jointly announced that they have entered into an exclusive license and collaboration agreement to develop and commercialize PIXUVRI(®) (pixantrone) in a transaction valued at up to EUR103.0 million (approximately $133.5 million) if all milestones are achieved. Under the agreement, CTI...

2014-09-12 23:05:19

North Texas Indoor Trampoline Park to Help Raise Money During the 2014-2015 School Year Frisco, Texas (PRWEB) September 12, 2014 Leukemia, the most common cancer in children under the age of 20 years old, affects about 4,103 school aged children every year in the US alone. For youth and their families, the diagnosis can be both mentally and financially crushing. In an effort to decrease these hardships and incentivize students to raise money for the cause, Urban Air Trampoline Park is...

2014-09-11 23:05:47

September is Blood Cancer Awareness Month, making it the perfect time to announce next year’s law school scholarship for survivors or family members affected by blood cancers. San Diego, California (PRWEB) September 11, 2014 September is Blood Cancer Awareness Month, a national event to bring much needed attention to these disorders. That makes September the perfect time to announce next year’s law school scholarship for survivors or family members affected by blood cancers. The Law...

2014-09-10 23:02:03

Lab Testing Company Encourages Bone Marrow Donation Participation Alpharetta, Ga. (PRWEB) September 10, 2014 September is Blood Cancer Awareness Month, observed by The Leukemia & Lymphoma Society as a means to raise awareness of blood cancers and efforts implemented to provide research and treatment. ANY LAB TEST NOW®, who has partnered with Delete Blood Cancer, is celebrating at select locations by encouraging customers to become donors by hosting swab parties, collecting...

2014-09-10 12:24:59

Thousands to Walk to Raise Funds for Blood Cancer Research SAN FRANCISCO, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Northern California Chapter will be kicking off its 2014 Light The Night(®) Walk campaign with the San Francisco Walk on September 23, 2014 at 5 p.m. PT at AT&T Park. The Light The Night Walk is a powerful and unique fundraising campaign from LLS, which brings together families and communities to honor blood cancer...

2014-09-10 12:24:45

Behind The Bench, The National Basketball Wives Association and The Leukemia & Lymphoma Society Team up for Cancer Cures WHITE PLAINS, N.Y., Sept. 10, 2014 /PRNewswire-USNewswire/ -- 11-year-old Kyle Markes passed away of acute lymphoblastic leukemia (ALL) on December 24, 2013, just days before he was set to be his idol Kevin Durant's special guest at an Oklahoma Thunder game on Christmas Day. Every three minutes, someone in the U.S. is diagnosed with a blood cancer. Almost 150,000...

2014-09-09 16:25:53

WHITE PLAINS, N.Y., Sept. 9, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) announced today that Louis J. DeGennaro, Ph.D., has been appointed as president and chief executive officer, effective immediately. http://photos.prnewswire.com/prnvar/20140909/144436 "Dr. DeGennaro has tirelessly dedicated himself for almost a decade of service to the LLS mission and to the patients whom we all serve, and this appointment is in recognition of his vision,...

2014-09-05 08:23:11

Newly Acquired SGX301 Orphan Drug Candidate Being Evaluated for Treatment of Cutaneous T-Cell Lymphoma PRINCETON, N.J., Sept. 5, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin). SGX301 is poised to enter...

2014-09-04 23:02:58

Topical research report “OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018” drawn up by GlobalData is now available at MarketPublishers.com. London, UK (PRWEB) September 04, 2014 The competitive landscape in the B-cell non-Hodgkin's lymphoma (NHL) markets in the USA, Germany, Italy, France, the UK and Spain is poised to undergo a noticeable shift over the forecast period. Disease treatment and management of the 4 largest B-cell NHL...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'